Clinical Trials Data Partnership Joins Verily with Pharma Giants

Verily Life Sciences, the healthcare subsidiary of Google parent Alphabet, said today it will partner with four pharma giants—Novartis, Otsuka Pharmaceutical, Pfizer, and Sanofi—to speed up clinical research and trials by improving data gathering through Verily’s Project Baseline tech platform and tools. The...

Clinical Trials Data Partnership Joins Verily with Pharma Giants

Verily Life Sciences, the healthcare subsidiary of Google parent Alphabet, said today it will partner with four pharma giants—Novartis, Otsuka Pharmaceutical, Pfizer, and Sanofi—to speed up clinical research and trials by improving data gathering through Verily’s Project Baseline tech...

Coffee Improves Gut Motility by Altering Gut Microbiota

Data presented yesterday at the Digestive Disease Week (DDW) 2019 Conference by researchers from University of Texas, Galveston, suggest that the effects of coffee on our bowels seem to have little to do with caffeine. Findings from the study—which were presented at the conference yesterday in a presentation entitled “In...
3D Rendered Illustration, cancer cell

Single-Cell Analysis of CTCs Improved via New Capture Technology

A team from the University of Michigan has recently developed Hydro-Seq, a new system to trap cancer cells one at a time in a blood sample, enabling comprehensive genetic profiling of cancer cells. “This could be a whole different ball game,” said Max Wicha, M.D., professor of oncology at the...
Fireworks in Brain

New Variant Uncovered that Predicts Huntington’s Onset Age

Researchers at the University of British Columbia (UBC)/Centre for Molecular Medicine & Therapeutics (CMMT) and BC Children’s Hospital recently uncovered a new genetic variant that helps predict Huntington’s disease onset by examining 25 years of data showing age of onset for Huntington’s disease patients. “This discovery may enable us to...
Abstract DNA.

Panel Identifies Hurdles to Wider AI Use in Diagnostic, Rx Development

Artificial intelligence (AI) is gaining a foothold in the discovery and development of drugs and diagnostics—but its use in both will remain limited unless companies surmount hurdles to the technology in the next few years, a panel of industry executives agreed.

Nearly One-in-Four Pediatric MATCH Patients Eligible for Treatment with Study Drugs

Nearly one-quarter (24%) of the 422 patients screened in the Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) trial are eligible for treatment with at least one drug being tested in the study, the National Cancer Institute (NCI) and the NCI-supported Children’s Oncology Group (COG) said. That’s more than double...

CRISPR Reveals Gene Fusions Critical for Cancer Cell Growth

In the first large-scale analysis of cancer gene fusions, researchers at the Wellcome Sanger Institute, EMBL-EBI, Open Targets, GSK and their collaborators have used CRISPR to uncover critical drivers of cancer cell growth.  One of the fusions they found appears to be a novel drug target for multiple cancers,...

Qiagen Wins FDA Clearance for QIAstat-Dx Syndromic Testing System, Respiratory Panel

Qiagen said today it has launched its QIAstat-Dx syndromic testing system along with the multiplex QIAstat-Dx respiratory panel after receiving FDA 510(k) clearances. QIAstat-Dx (formerly STAT-Dx DiagCORE) is a next-generation multiplex molecular diagnostic system designed to enable fast, cost-effective and flexible syndromic testing with novel “Sample to Insight” solutions applying...

Microfluidic Chip Captures More than 99% of CTCs

Scientists at the University of Georgia (UGA) College of Engineering have developed a new microfluidic device that separates circulating tumor cells (CTCs) from a sample of whole blood. The team, led by Leidong Mao, Ph.D., a professor in UGA’s School of Electrical and Computer Engineering, calls its novel approach...
Portrait of business people in crowd

All of Us Launches Beta Version of Interactive Data Browser

The NIH has announced the beta launch of its interactive Data Browser, which allows users to get an early look at the types of data participants in the  All of Us are sharing with the research program. To date, more than 192,000 people have enrolled in the program that has...

GE Healthcare, Indi Molecular to Collaborate on Immunotherapy Diagnostic

GE Healthcare, and theranostics company Indi Molecular have entered a collaboration to develop non-invasive positron emission tomography (PET) tracers that target the CD8 protein. PD-1-expressing CD8+ T lymphocytes are thought to play a significant role in response to immune checkpoint inhibitor therapies and are a key predictor of immunotherapy...

Rethinking Rx-Dx Codevelopment

Sponsor: Molecular MD. Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Liquid Biopsy and ddPCR: A Match with Quality in Mind

Sponsor: Bio Rad. In this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.
Scroll Up